Fluorination process of anilide derivatives and benzothiazole fluorinate derivatives as in vivo imaging agents

Details for Australian Patent Application No. 2006281216 (hide)

Owner GE Healthcare Limited GE Healthcare AS

Inventors Langstrom, Bengt; Karimi, Farhad; Lasbistes, Nicolas; Storey, Anthony Eamon; Nairne, Robert James; Gibson, Alexander Mark; Fairway, Steven Michael; Bouvet, Denis Raymond Christophe; Jones, Clare Louise; Williams, Lorenzo

Agent Davies Collison Cave

Pub. Number AU-B-2006281216

PCT Pub. Number WO2007/020400

Priority 0516564.2 12.08.05 GB

Filing date 11 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 19 January 2012

International Classifications

C07C 17/093 (2006.01) Compounds containing carbon and halogens with or without hydrogen

A61K 31/428 (2006.01) - condensed with carbocyclic rings

C07D 277/66 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/020400 Priority application(s): WO2007/020400

19 January 2012 Application Accepted

  Published as AU-B-2006281216

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281227-Amide derivatives

2006281204-Pharmaceutical compositions comprising metals for modulating epithelial cellto-cell adhesion